Russian stocks are cheap for a reason

Russia may be cheap – but that certainly doesn’t make it good value. If its stand-off with the West goes on, Russia could become a total pariah state in investment terms.


Russian markets are at the mercy of the US Treasury
(Image credit: This content is subject to copyright.)

"You make more money when things go from truly awful to merely bad," says Arjun Divecha of asset management group GMO, "than when they go from good to great." So value investors should be eyeing up Russia. Its "relationship with the world is now approaching truly awful".

Since 6 April, when the US announced a new round of sanctions against Russian individuals and firms, the rouble has had its worst week against the US dollar since 1999, losing over 7%. The RTS stockmarket index slumped by 11% in a day; and the yield on government bonds has leapt by over 0.5%, reflecting sliding prices. Even before the slump, Russian assets were cheap. Stocks were on a forward price-earnings ratio of 6.5, compared with 12.5 for emerging markets as a whole, says Steve Johnson in the Financial Times.

The economy is recovering

The fundamentals, moreover, looked mildly encouraging. After a recession and jump in inflation, the central bank had got price rises under control, facilitating a long series of interest-rate cuts. These spurred a jump in bank lending, underpinning growth and allowing Russia to regain its investment-grade credit rating.

Subscribe to MoneyWeek

Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Get 6 issues free

Sign up to Money Morning

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Sign up

Nonetheless, the economic recovery is far from spectacular: the International Monetary Fund has forecast annual growth of just 1.7% in 2018, and there is no sign of structural changes such as reducing the role of the state that would raise the economy's speed limit. The latest slump in the rouble could prevent further interest-rate cuts, says Johnson, which would crimp growth.

But the bigger problem is that geopolitics are now the main influence on stock prices, and this is fraught with risk. Washington has now imposed secondary sanctions on various Russian companies and people, so non-US individuals and firms doing business with the sanctioned firms and people face the same penalties as Americans. This implies that "several Russian entities and businessmen long serving as conduits for Western investment into the country now face crippling restrictions on their reach in international markets", says Natasha Turak on CNBC. "Anyone could be next", and the upshot is that Russia's markets "now appear at the mercy" of the United States Treasury.

If this stand-off goes on, Russia could become a total pariah state in investment terms, says Rob Marstrand on Seeking Alpha. How long will it be before the US and UK ban all trading of Russian stocks and bonds? On top of all this we have the usual problem of a capricious Russian state, which on this occasion may attempt to punish foreign investors or seize their holdings to top up the coffers. Russia may be cheap but that certainly doesn't make it good value.

Andrew Van Sickle

Andrew is the editor of MoneyWeek magazine. He grew up in Vienna and studied at the University of St Andrews, where he gained a first-class MA in geography & international relations.

After graduating he began to contribute to the foreign page of The Week and soon afterwards joined MoneyWeek at its inception in October 2000. He helped Merryn Somerset Webb establish it as Britain’s best-selling financial magazine, contributing to every section of the publication and specialising in macroeconomics and stockmarkets, before going part-time.

His freelance projects have included a 2009 relaunch of The Pharma Letter, where he covered corporate news and political developments in the German pharmaceuticals market for two years, and a multiyear stint as deputy editor of the Barclays account at Redwood, a marketing agency.

Andrew has been editing MoneyWeek since 2018, and continues to specialise in investment and news in German-speaking countries owing to his fluent command of the language.